Dong Sung Bio Pharm.Co.,Ltd.
Symbol: 002210.KS
KSC
5240
KRWMarktpreis heute
-57.7739
P/E-Verhältnis
-0.8344
PEG-Verhältnis
119.82B
MRK Kapital
- 0.00%
DIV Rendite
Dong Sung Bio Pharm.Co.,Ltd. (002210-KS) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 21733.89 | 6435.4 | 4093.8 | 5142.8 | |||||||||||||||||
balance-sheet.row.short-term-investments | -3073.9 | 0 | 0 | 2002.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 127499.54 | 31290.9 | 35361.6 | 29324.5 | |||||||||||||||||
balance-sheet.row.inventory | 72346.52 | 19477.1 | 14933.8 | 15519.1 | |||||||||||||||||
balance-sheet.row.other-current-assets | 16601.77 | 3611.5 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-current-assets | 238181.72 | 60814.9 | 54389.2 | 49986.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 172690.32 | 42725.5 | 43960.4 | 37377.8 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 3645.02 | 978.8 | 855.8 | 942.7 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3645.02 | 978.8 | 855.8 | 942.7 | |||||||||||||||||
balance-sheet.row.long-term-investments | 12525.06 | 7719.6 | 510.2 | -1606.9 | |||||||||||||||||
balance-sheet.row.tax-assets | 11078.52 | 0 | -510.2 | 17882 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 18636.95 | 2734.6 | 8496.6 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 218575.87 | 54158.4 | 53312.9 | 54595.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 456757.59 | 114973.3 | 107702.1 | 104581.9 | |||||||||||||||||
balance-sheet.row.account-payables | 47580.16 | 11261.1 | 8852 | 6858.8 | |||||||||||||||||
balance-sheet.row.short-term-debt | 112670.19 | 24732.5 | 29274 | 19714 | |||||||||||||||||
balance-sheet.row.tax-payables | 66.53 | 0 | 418.8 | 262.1 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 52132.34 | 18522.4 | 7761.9 | 9600.8 | |||||||||||||||||
Deferred Revenue Non Current | 17174.11 | 17.9 | 0 | 9113.3 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10739.73 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 60212.7 | 8850.2 | 9183.7 | 3729.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 95537.15 | 30327.1 | 17321.6 | 20552.3 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 231.81 | 17.9 | 104.1 | 55.7 | |||||||||||||||||
balance-sheet.row.total-liab | 289693.7 | 75171 | 64892.8 | 58141.5 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 104403.88 | 26101 | 26101 | 26101 | |||||||||||||||||
balance-sheet.row.retained-earnings | 4190.1 | -3006.9 | 1153.1 | -2570.8 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 11151.02 | 2787.8 | 2787.8 | 2787.8 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 47318.89 | 13920.5 | 12767.5 | 20122.4 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 167063.89 | 39802.3 | 42809.3 | 46440.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 456757.59 | 114973.3 | 107702.1 | 104581.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 167063.89 | 39802.3 | 42809.3 | 46440.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 456757.59 | - | - | - | |||||||||||||||||
Total Investments | 9451.15 | 7719.6 | 510.2 | 395.7 | |||||||||||||||||
balance-sheet.row.total-debt | 164820.39 | 43272.8 | 37035.8 | 29314.8 | |||||||||||||||||
balance-sheet.row.net-debt | 147179.16 | 36837.4 | 32942 | 26174.6 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2073.91 | -2073.9 | -2121.7 | -4312.8 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2082.09 | 2046 | 2119.7 | 2222.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -5165.38 | -5165.4 | -4348.3 | -2543.3 | |||||||||||||||||
cash-flows.row.account-receivables | 2887.7 | 2887.7 | -4280.9 | -1791.5 | |||||||||||||||||
cash-flows.row.inventory | -3965.32 | -3965.3 | 629.7 | 4466.7 | |||||||||||||||||
cash-flows.row.account-payables | 1519.79 | 1519.8 | 1995 | -2870.6 | |||||||||||||||||
cash-flows.row.other-working-capital | -5607.55 | -5607.6 | -2692.1 | -2348 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 863.87 | 900 | 467.6 | 1882 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -4293.33 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -923.56 | -923.6 | -642.9 | -2323.5 | |||||||||||||||||
cash-flows.row.acquisitions-net | 32.78 | 18.2 | 74.3 | -197.7 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -48.49 | -57.5 | -56.2 | -10994.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -32.78 | 0 | 2019.9 | 14989.6 | |||||||||||||||||
cash-flows.row.other-investing-activites | 44.34 | 35.2 | -756.9 | -11173.2 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -927.71 | -927.7 | 638.3 | -9699.8 | |||||||||||||||||
cash-flows.row.debt-repayment | -33936.52 | -1229.6 | -44052.3 | -26435.5 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 8455.4 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -1996.4 | -2990.4 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -8455.4 | |||||||||||||||||
cash-flows.row.other-financing-activites | 41503.88 | 8797 | 50289 | 30657.7 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 7567.35 | 7567.4 | 4240.2 | 1231.8 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -4.71 | -4.7 | -42.3 | 7.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 2341.6 | 2341.6 | 953.6 | -11211.9 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 17641.23 | 6435.4 | 4093.8 | 3140.2 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 15299.63 | 4093.8 | 3140.2 | 14352.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -4293.33 | -4293.3 | -3882.6 | -2751.5 | |||||||||||||||||
cash-flows.row.capital-expenditure | -923.56 | -923.6 | -642.9 | -2323.5 | |||||||||||||||||
cash-flows.row.free-cash-flow | -5216.9 | -5216.9 | -4525.5 | -5075.1 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 88593.59 | 88593.6 | 93328.2 | 84407.7 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 47447.64 | 47943.9 | 51272.8 | 50864 | |||||||||||||||||
income-statement-row.row.gross-profit | 41145.95 | 40649.6 | 42055.4 | 33543.6 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 4169.12 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 12376.07 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 24762.64 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -20425.25 | -221 | 12200 | 12364.1 | |||||||||||||||||
income-statement-row.row.operating-expenses | 18666 | 40053.2 | 45152.4 | 38842.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 77055.41 | 87997.2 | 96425.2 | 89706.7 | |||||||||||||||||
income-statement-row.row.interest-income | 63.26 | 63.3 | 47.1 | 76.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 2240.91 | 2240.9 | 1307.8 | 712.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 24762.64 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -1462.29 | -1462.3 | 191.2 | 919.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -20425.25 | -221 | 12200 | 12364.1 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -1462.29 | -1462.3 | 191.2 | 919.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 2240.91 | 2240.9 | 1307.8 | 712.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 12820.26 | 2046 | 2119.7 | 3980.6 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 13416.67 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 596.4 | 596.4 | -2041.8 | -5299 | |||||||||||||||||
income-statement-row.row.income-before-tax | -865.89 | -865.9 | -1850.6 | -4379.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 1208.02 | 1208 | 271.1 | -66.5 | |||||||||||||||||
income-statement-row.row.net-income | -2073.91 | -2073.9 | -2121.7 | -4312.8 |
Häufig gestellte Frage
Wie hoch ist die Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) Gesamtvermögen?
Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) Gesamtvermögen ist 114973284037.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 43786401591.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.464.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -228.151.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -0.023.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.007.
Was ist der Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -2073909512.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 43272811605.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 40053242263.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 6435381432.000.